Ranjit Bindra on Navigating Dynamics with Parents in Pediatric Oncology

Video

Dr. Ranji Bindra explains the delicate balance that must go into treating the parents of patients in pediatric oncology.

Ranjit Bindra, MD, PhD, from Smilow Cancer Hospital at Yale explains the importance of communicating honestly and sensitively with parents when treating pediatric patients.

In pediatric oncology, nurses have to treat both the patient and the family. This requires a delicate balance that allows the parents to be hopeful and engaged, but realistic. Bindra highlights the importance of revising communication in relation to the patient's status.

Recent Videos
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
5 experts in this video
5 experts in this video
Screen capture of Seth Eisenberg, ASN, RN, OCN, BMTCN, on a video call with an Oncology Nursing News branded border around the frame
Image of a woman with glasses wearing a striped blouse and a black sweater in front of an Oncology Nursing News branded backdrop
Related Content
Illustration of a person looking upset, with their head on their knees

Intro to AYA Patients, Survivors, and Substance Use

Christina Monaco, LMSW
February 5th 2025
Article

Adolescent and young adult survivors of cancer face increased substance use risks due to developmental delays, limited support, and coping mechanisms, necessitating targeted prevention.

The Vitals

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials

Lindsay Fischer
July 15th 2023
Podcast

Jacki Garcia, RN, BSN, CNRN; and Kristin Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.

image of brain representing central nervous system

Larotrectinib Is Promising for Pediatric TRK Fusion-Positive CNS Tumors

Ryan Scott
November 26th 2024
Article

Larotrectinib led to rapid/durable responses and high disease control rates in children with TRK fusion-position central nervous system cancers.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

clinician pointing toward "FDA"

FDA Grants Rare Pediatric Designation to Elraglusib for Ewing Sarcoma

Ryan Scott
November 15th 2024
Article

The FDA granted elraglusib a rare pediatric disease designation for Ewing sarcoma based on findings from the 1/2 Actuate-1902 trial.

FDA on blue background

Virus Therapy Gets Orphan Drug Designation for Glioma Treatment

Ryan Scott
November 10th 2024
Article

The FDA granted an orphan drug designation to herpes simplex virus type 1 (HSV-1) oncolytic virus MB-108 for malignant glioma treatment.